JOSEPH KLEIN, III - Corporate Board Profile

IONIS PHARMACEUTICALS INC

Filing Date	Source Excerpt
2018-04-11	Joseph Klein, III, age 56, has served as a Director of Ionis since December 2005. Mr. Klein is currently Managing Director of Gauss Capital Advisors, LLC, a financial consulting and investment advisory firm focused on biopharmaceuticals, which he founded in March 1998. From September 2003 to December 2008, Mr. Klein also served as a Venture Partner of Red Abbey Venture Partners, L.P., a life science private equity fund. From September 2001 to September 2002, Mr. Klein was a Venture Partner of MPM Capital, a healthcare venture capital firm. From June 1999 to September 2000 when it merged with WebMD Corporation, Mr. Klein served as Vice President, Strategy, for Medical Manager Corporation, a leading developer of physician office management information systems. For over nine years from 1989 to 1998, Mr. Klein was a health care investment analyst at T. Rowe Price Associates, Inc., where he was the founding portfolio manager of the T. Rowe Price Health Sciences Fund, Inc. Mr. Klein serves on the board of directors of The Prospector Funds, Inc., an SEC Registered Investment Company that manages two no-load mutual funds. Mr. Klein also serves on the boards of private and non-profit entities. The Board believes that Mr. Klein is uniquely suited to serve on the Board and the Audit Committee because he is a Chartered Financial Analyst and has extensive public company, venture investment, board, and financial advisory expertise in the life sciences industry, including previously serving as Chairman of the Audit Committee at several public biopharmaceutical companies. In 2017, Mr. Klein received $67,000 in cash compensation and stock and option awards with an aggregate fair value of $636,941.
2019-04-26	Joseph Klein, III, age 57, has served as a Director of Ionis since December 2005. ... The Board believes that Mr. Klein is uniquely suited to serve on the Board and as chairman of the Audit Committee because he is a Chartered Financial Analyst and has extensive public company, venture investment, board, and financial advisory expertise in the life sciences industry.
2020-04-24	Director Compensation for Fiscal 2019 Joseph Klein, III Cash Compensation Earned or Paid ($): $76,000 Stock Awards ($): $460,728 Option Awards ($): $607,645 All Other Compensation ($): $22,074 Total ($): $1,166,447
2021-04-23	Joseph Klein, III, age 59, has served as a Director of Ionis since December 2005. ... Director Compensation for Fiscal 2020 ... Joseph Klein, III ... Total ($) $937,085.
2022-04-20	Joseph Klein, III, age 60, has served as a Director of Ionis since December 2005 and is Chairman of the Audit Committee. ... Mr. Klein is currently Managing Director of Gauss Capital Advisors, LLC, a financial consulting and investment advisory firm focused on biopharmaceuticals, which he founded in March 1998. ... The Board believes Mr. Klein is uniquely suited to serve on the Board and as Chairman of the Audit Committee because he is a Chartered Financial Analyst and has extensive public company, venture investment, board, and financial advisory expertise in the life sciences industry, including previously serving as Chairman of the Audit Committee at several public biopharmaceutical companies. ... The table shows for the fiscal year ended December 31, 2021 certain information with respect to the compensation of our Directors: ... Joseph Klein, III: Cash Compensation $84,000, Stock Awards $213,587, Option Awards $273,240, Total $593,840.